ROC curves showed that the expression level of Ano1 was discriminated by PR (P=0.040), TNBC (P=0.051), and tamoxifen treatment (P=0.017) (Figure 2), and the expression level of Ki67 was discriminated by tumor size (P=0.028), clinical stages (P=0.004), and HER2 status (P=0.003) (Figure 3). This evidence concerns the gene ANO1 and neoplasm.